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 Despite the well-known health benefits associated with physical activity 
(PA), the majority of people with Parkinson’s disease (pwPD) and people with 
stroke do not meet national PA guidelines. As a result, these two groups of 
people are at increased risk for development of cardiovascular disease, 
additional disability and death.  
 Walking as a mode of PA has been shown to improve the health of both 
pwPD and people with stroke. In fact, a step count of >6000 steps per day is 
related to a decreased risk of subsequent cardiovascular events in people with 
stroke. Daily walking is also strongly recommended by the U.S. surgeon general 
and national PA guidelines. Currently, however, guidelines do not recommend a 
specific daily step count for pwPD or stroke and the relationship between daily 
steps and health in these individuals is unclear. 
 The overall purpose of the following two studies was to identify daily step 
counts associated with health outcomes in pwPD and people with stroke. 
Specifically for pwPD (Chapter 2), the purpose was to 1) determine a step 
threshold that corresponds to meeting aerobic PA guidelines, 2) determine 
effects of treadmill exercise performed at varying intensities on PA and 3) 
quantify the relationship between changes in daily steps and fitness. For people 
with stroke (Chapter 3) the purpose was to 1) determine which factors at two 




what step count at two months corresponds to obtaining >6000 daily steps at one 
year post-stroke. 
 Data for both studies were obtained from publicly available datasets. The 
first study included 110 individuals with de novo Parkinson’s disease who were 
allocated to one of three groups (high-intensity treadmill exercise, moderate-
intensity treadmill exercise or control) for six months. Baseline step data and 
Receiver Operating Characteristic (ROC) curves were used to determine which 
step count corresponded to meeting PA guidelines. The effect of treadmill 
exercise on PA was examined in those below the step threshold (i.e. the least 
active participants). Pearson’s r correlations determined the relationship between 
daily steps and fitness. The second study included 206 participants with stroke 
who were allocated to one of three groups (36 sessions of body weight–
supported treadmill training at two months post-stroke, 36 sessions of body 
weight–supported treadmill training at six months post-stroke, or 36 sessions of 
progressive supervised home exercise program). Daily steps were assessed at 
two months and one year post-stroke. Linear regression was used to predict daily 
step counts at one year based on factors including age, gender, race and/or 
ethnicity, stroke severity, walking speed and endurance, fitness, motor function, 
balance and balance confidence. A Receiver Operating Characteristic (ROC) 
curve determined which step count corresponded to reaching >6000 steps at one 
year. 
Results indicate that for pwPD, a daily step count of >4200 corresponds to 




intensity treadmill exercise led to improvements in daily steps but these changes 
were not associated with changes in fitness. Overall, pwPD should be 
encouraged to take >4200 daily steps in order to meet PA guidelines through 
walking. For people with stroke, daily steps and balance at two months post-
stroke were the strongest predictors of future daily steps. Thus, improving daily 
PA and balance early after stroke may be necessary to increase PA levels at one 
year post-stroke. A step count of >1632 steps per day at two months post-stroke 
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CHAPTER 1: INTRODUCTION 
 Lack of physical activity (PA) is a global public health problem.1 While 
nearly half of U.S. adults are not meeting PA guidelines,2 for adults living with 
movement disability the prevalence of inactivity is even higher.3 Of the nearly 
930,000 U.S. adults with Parkinson’s disease (PD),4 only 27% are meeting PA 
guidelines5 and of the 6.8 million people in the U.S. with stroke,6 only 18% are 
meeting PA guidelines.7 High levels of inactivity for people with PD (pwPD) and 
stroke is a substantial problem as both groups are at a heightened risk for 
cardiovascular disease, further disability and premature death,8–12 all of which 
can be mitigated through performing adequate amounts of PA.  
 Various modes of PA have proven health benefits for pwPD and stroke. 
Walking, in particular, has been shown to improve walking speed,13 
cardiorespiratory fitness,13–15 fatigue, depression, quality of life and slow disease 
progression15 in pwPD. Similarly, for individuals with stroke, walking interventions 
have led to improvements in walking speed,16 walking endurance17 and 
cardiorespiratory fitnesss.18 Walking as a mode of PA is also strongly 
recommended by the U.S. surgeon general19 and the 2018 PA Guidelines for 
Americans, which state that individuals with chronic health conditions should 
perform at least 150 weekly minutes of moderate-intensity aerobic PA.20 
Unfortunately, these guidelines are not being met by the majority of pwPD or 




steps) are warranted. One limitation with current guidelines is that measuring and 
tracking PA intensity requires individuals to assess intensity through heart rate, 
respiratory rate, perceived effort, or speed (among others), which may be difficult 
for individuals with cognitive impairment from PD or stroke. Daily step counts, on 
the other hand, provide users with a single metric that is easy to understand and 
can be used to set goals and track individual progress. In addition, daily steps 
can be measured relatively inexpensively and accurately using commercially 
available wearables.5,21–23 
 While current PA guidelines recommend walking, they do not endorse a 
specific daily step count and research involving clinical populations is sparce. 
Previous research has suggested 7000 to 1000024 steps per day is appropriate 
for healthy older adults to achieve health benefits through walking. PwPD and 
stroke, however, often have walking impairments,25,26 making these 
recommendations unrealistic and unobtainable.27,28 For example, pwPD take 
2300 less steps than their age-matched peers27 and daily steps decrease as the 
disease progresses.29,30 People with stroke may walk even less, averaging 4000 
fewer steps per day compared to healthy adults.28 While higher levels of PA (or 
steps) provide additional health benefits, lower levels may still be beneficial. Lee 
et al31 examined nearly 17,000 older women (mean age=72 years) across four 
years and found that just 4400 steps per day was related to a 41% decrease in 
mortality rates compared to 2700 steps per day. Additionally, mortality rates 
continued to decrease until reaching a plateau at 7500 steps per day. 




importance of step intensity was reduced, which led the authors to conclude that 
daily step counts may be of greater value than metrics of intensity.  
 Overall, there is little evidence to guide daily step recommendations for 
those with PD or stroke. Additionally, few interventions to date have successfully 
increased daily steps in these populations.14,16,32,33 Therefore, using two large 
and publicly available datasets, the purpose of the following two studies was to 
identify daily step counts associated with health outcomes and provide data that 
can be used to inform future interventions aimed at improving PA in those with 
PD or stroke. Specifically, for people with PD (Chapter 2), there were three 
questions targeted:  
 1) What daily step threshold corresponded to meeting PA guidelines?  
 2) For those below the determined daily step threshold, what were the 
 effects of treadmill exercise performed at varying intensities on daily steps 
 and moderate-to-vigorous intensity PA (MVPA)?  
 3) For those below the determined daily step threshold, what was the 
 relationship between changes in daily steps and cardiorespiratory fitness?  
For people with stroke (Chapter 3), there were two aims:  
 1) Determine which factors (both nonmodifiable and modifiable) present at 
 two months post-stroke can predict daily step counts at one year post-
 stroke. 
 2) Determine a daily step threshold at two months post stroke that 





CHAPTER 2: PHYSICAL ACTIVITY IN DE NOVO PARKINSON’S 
DISEASE: DAILY STEP RECOMMENDATION AND EFFECTS OF 
TREADMILL EXERCISE ON PHYSICAL ACTIVITY 
INTRODUCTION 
 Parkinson’s disease (PD) is a progressive degenerative neurological 
disease that reduces function, independence, and quality of life for millions of 
people around the world.34 Physical activity (PA) and more specifically walking, 
has been shown to improve walking speed,13 cardiorespiratory fitness,13–15 
fatigue, depression, quality of life and slow disease progression.15 Walking is also 
strongly recommended by the U.S. surgeon general19 and the 2018 PA 
Guidelines for Americans.20 Unfortunately, people living with PD are 29% less 
physically active than those without,35 and, as the disease progresses, daily step 
counts and PA levels also decrease.29,30 Therefore, there is an urgent need for 
interventions aimed at increasing PA levels in pwPD.  
 Steps are an appealing method of objectively measuring PA in pwPD 
given they can easily be captured and displayed using inexpensive commercially 
available wearables. Additionally, because nearly one third of people newly 
diagnosed with PD exhibit mild cognitive impairment,36  steps may be an 
especially preferential PA target as they provide a single and simple metric to 




as the number needed to meet PA guidelines in healthy older adults, there is no 
current step recommendation for those with PD and the relationship between 
steps and other established health outcomes such as cardiorespiratory fitness37 
is unclear.  
 Most research regarding step counts in pwPD has been from cross 
sectional assessments.5,27,38–40 To date, few interventions have examined 
changes in daily steps in pwPD. Two recent randomized controlled trials which 
used walking for exercise as the intervention found no significant changes in 
daily steps.14,33 These null findings are of interest, especially considering that 
both interventions recruited individuals who reported not being regular exercisers 
prior to study onset. In the Study in Parkinson’s Disease of Exercise (SPARX) 
trial,14,41 which had two exercise groups and one control group, authors 
suggested that those in the exercise groups may have reduced the number of 
steps taken outside the intervention so that average daily steps remained 
unchanged. While this may have been true when considering the entire sample, 
what about the individuals who were the least active? Would they see meaningful 
improvements in steps, PA, and/or other health outcomes as a result of the 
exercise intervention? 
 Using data from the SPARX trial, the present study examined the effects 
of treadmill exercise on PA levels in people with de novo PD. We analyzed the 
least active participants, as these individuals arguably have the most to gain (in 
terms of health benefits) from increasing PA. Specifically, there were three aims: 




those below the determined daily step threshold, what were the effects of 
treadmill exercise performed at varying intensities on daily steps and moderate-
to-vigorous intensity PA (MVPA)? 3) For those below the determined daily step 
threshold, what was the relationship between changes in daily steps and 
cardiorespiratory fitness?  
METHODS 
Study Design and Participants 
 This research is based on a deidentified dataset obtained from the 
National Institute of Neurologic Disease and Stroke’s (NINDS) Archived Clinical 
Research data (Study in Parkinson’s Disease of Exercise [SPARX], Margaret 
Schenkman, PT, PhD, NCT01506479) received from the Archived Clinical 
Research Dataset website. The SPARX trial was a multicenter, randomized, 
controlled, single-assessor-blinded, Phase II study.41 Participants with de novo 
PD were randomized to one of three groups: high-intensity treadmill exercise (80-
85% maximum heart rate [HRmax]), moderate-intensity treadmill exercise (60-
65% HRmax) or a waitlist control who received usual care. All participants from 
the SPARX trial provided informed consent and the study was approved by 
associated institutional review boards.14 The present secondary analysis 
received exemption from the University of South Carolina’s institutional review 
board. 
 Recruitment procedures, inclusion and exclusion criteria for the SPARX 
trial have previously been described.14,41 In summary, included participants were 




less than III and who were in the early stages of PD and naïve to therapy (also 
known as de novo).42–44 Individuals were excluded if they were currently being 
treated pharmacologically for PD, unable to perform high-intensity exercise or if 
they reported regularly (>2 days/week for > 4 months) participating in moderate 
to vigorous aerobic exercise. To be included in the present study, participants 
were required to have step data at baseline (i.e. before intervention) for aim one, 
step or VO2peak data at baseline and at five and/or six months for aim two and 
both step data and VO2peak data at baseline and at five and/or six months for 
aim three. A flow diagram demonstrating how participant data were utilized is 
displayed in Figure 1. 
Treadmill Exercise Intervention & Waitlist Control Group 
 Both high-intensity and moderate-intensity exercise groups were 
prescribed the same mode, frequency and duration of exercise, which was 
treadmill exercise (i.e. walking) performed 4 days/week for 26 weeks with 45 
minute sessions.14 Frequency and intensity of exercise were gradually increased 
for the first 8 weeks of the intervention until target HR levels were reached. 
Treadmill speed and/or incline was adjusted to maintain target HR. Both high and 
moderate-intensity exercise groups met the prescribed exercise intensities and 
frequencies over the six month intervention, demonstrating intervention fidelity.14 








 Participant age, sex, time since Parkinson’s disease diagnosis, Movement 
Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) motor 
score (part III),45 item 9 on the Parkinson’s Disease Questionnaire - 39 (PDQ-
39)46 and the presence or absence of a cardiovascular health condition (e.g. 
hypertension) were used to describe the sample. Previous literature found these 
factors to be significant explanatory variables for daily steps, with higher daily 
step counts associated with less time since diagnosis, lower MDS-UPDRS motor 
scores, no reported fear or worry of falling (Item 9 of the PDQ-39) and the 
presence of a cardiovascular condition.37  
Activity Monitoring 
 To capture PA (steps and activity counts), participants were instructed to 
don a waist-worn Actigraph GT3X [+ and BT]; Actigraph, Pensacola, Florida) 
during waking hours over a 10-day period, once a month for the duration of the 
six month (26 week) intervention.37,41 The activity monitors have demonstrated 
moderate to high validity and reliability in assessment of free-living activity47–49 
and steps in pwPD.5,21  Steps and activity counts were summed over each 60 
second epoch and then averaged over total monitor wear time. With the 3-axis 
activity monitor, steps are based on vertical axis acceleration whereas activity 
counts are based on acceleration in all 3-axes and reflect the frequency and 
intensity of movement.37 Activity counts per minute of wear time were used to 




moderate (1952-5724 counts/min) and vigorous (>5725 counts/min) intensity 
PA.50,51  
 Valid activity monitoring days were considered those with at least 10 hours 
of valid wear time and a maximum of 90 minutes of non-wear time.37,52 For each 
assessment point (i.e. baseline and five and/or six months) participants needed 
at least four valid days to be included in the analysis. To examine the effect of 
treadmill exercise on average daily step counts (aim two), participants in the two 
exercise groups (i.e. high and moderate intensity treadmill exercise) were 
required to have at least two treadmill exercise session in which steps (and 
activity counts) were recorded. If activity data were available at both five and six 
months, these data were averaged, whereas if data were only available for one 
of these timepoints, these data were used. We chose to examine activity data at 
five and/or six months when present as it was postulated that this would 
represent the peak activity levels during the progressive six month intervention. 
Cardiorespiratory Fitness 
 Assessment of cardiorespiratory fitness was performed at baseline and at 
six months via a maximal graded exercise test (treadmill walking) with 
assessment of VO2peak (mL/min/kg) by indirect calorimetry and HRmax.37,41 
Treadmill walking speed was adjusted so that participants were exercising at 
70% of their age-predicted maximum heart rate. Participants using chronotropic 
medications walked at a speed that corresponded to a 4 out of 10 on the 




Data Analysis  
 Descriptive statistics were calculated for all participants with valid baseline 
step data. The Shapiro-Wilk test was used to assess all data for normality.55 
Using baseline (prior to intervention) activity data, participants were first 
categorized as “meeting” or “not meeting” aerobic PA guidelines, which states 
individuals should perform >150 weekly minutes of moderate intensity aerobic 
PA.20 Average daily activity minutes (measured via activity monitor) performed at 
a moderate intensity or greater was multiplied by seven for an estimate of weekly 
PA for each participant. Accumulation of vigorous activity was low (less than one 
second per hour for those not meeting guidelines) and therefore was combined 
to form MVPA.5  To determine the diagnostic accuracy of average daily step 
count and VO2peak (independent variables) to correctly classify those who meet 
PA guidelines (dependent variable), receiver operating characteristic (ROC) 
curves, including the area under the curve (AUC), were generated.56 Sensitivity, 
specificity, likelihood ratios and Youden’s index (J)57 were also calculated. The 
single highest J value was chosen as the optimal threshold58 to accurately 
classify participants as “meeting” or “not meeting” PA guidelines (i.e. >150 or 
<150 minutes of at least moderate-intensity PA). Based on the determined step 
threshold, participants were dichotomized into two step groups (i.e. participants 
above and below the step threshold), with participant descriptors and PA 
variables (e.g. steps, moderate intensity PA) compared with independent t-tests 




 A comparison within and between subjects was made for participants 
below the determined step threshold in each of the three SPARX groups (i.e. 
high-intensity exercise, moderate-intensity exercise and waitlist control). Three 
separate Mixed-Design Two-Way Repeated Measures Analysis of Variance 
identified differences in the dependent variables of daily steps, MVPA and 
VO2peak between assessment points (baseline and five and/or six months), 
groups, and/or the interaction between time and group. A Bonferroni adjustment 
was applied to control for multiple comparisons. Post-hoc tests (i.e. t-tests or one 
way analysis of variance) were performed and effect sizes (Cohen’s d) were then 
calculated to determine the effects of treadmill exercise performed at varying 
intensities on PA. Effect sizes of 0.8 were considered large, 0.5 were considered 
medium and 0.2 were considered small.59 The relationship between changes in 
daily steps and VO2peak were examined using Pearson’s r correlations. 
 Alpha level was set at <.05 for all statistical tests, and all analyses were 
performed using IBM SPSS Statistics for Macintosh, Version 26.0 (IBM SPSS, 
Chicago, IL, USA).  
RESULTS 
Step threshold that corresponds to meeting aerobic PA guidelines 
 Of the 110 participants with valid PA data at baseline (Figure 1), 84 
(76.4%) had > 150 weekly minutes of MVPA and thus met aerobic PA guidelines 
(Table 1). ROC curves are displayed in Figure 2. Resulting thresholds that 
corresponded to meeting aerobic PA guidelines were 4197 daily steps and a 




threshold of 4197 daily steps correctly classified 87% (sensitivity) of participants 
who met/exceeded PA guidelines and 96% (specificity) of people who did not 
meet PA guidelines. A comparison of participants with >4200 and <4200 daily 
steps is displayed in Table 1. Those averaging <4200 daily steps were older, 
more likely to report a fear of falling and had lower baseline fitness levels. 
Effects of treadmill exercise performed at varying intensities on PA  
 Of the 36 participants with an average of <4200 daily steps, 33 had the 
appropriate data and were analyzed (Figure 1). Descriptive baseline data for the 
33 participants, including group allocation are displayed (Table 3). At five and/or 
six months, 85.7% (12/14), 33.3% (2/6) and 23.1% (3/13) of participants met PA 
guidelines in the high-intensity, moderate-intensity and waitlist control groups, 
respectively (data not in table). 
 At five and/or six months, participants in the high intensity group (n=14) 
had a median of 5.5 (2, 11) treadmill exercise sessions with activity monitoring 
and averaged 2604 (1283) steps per session, whereas those in the moderate 
intensity group (n=6) had a median of 7.5 (2, 9) treadmill exercise sessions with 
activity monitoring and averaged 1809 (1418) steps; neither number of exercise 
sessions with activity monitoring nor average steps were statistically different 
(p=0.54 and p=0.23, respectively). Average daily activity monitor wear time at 
five and/or six months was not significantly different between the three groups 
(p=0.60; high-intensity group 817 (138), moderate-intensity group 765 (99) and 
waitlist control 795 (114) minutes per day). Analysis of daily steps revealed a 




time*group interaction (p=0.10, Figure 3). Subsequent paired t-tests revealed that 
the high-intensity group significantly increased daily steps by 1220 (1614) steps 
(p=.01, 95% CI  288 to 2152) whereas within group differences in steps for the 
moderate-intensity group and the waitlist control group did not reach statistical 
significance: 435 (845) steps (p=.26, 95% CI -452 to 1322) and 85 (1207) steps 
(p=.80, 95% CI -644 to 815, respectively). Within group effect sizes (Cohen’s d) 
for changes in average daily steps were 0.98, 0.52 and 0.08 for high intensity, 
moderate intensity and waitlist control groups, respectively. 
 For MVPA, there was a main effect for time (p=0.01) and group (p=0.02) 
but no statistically significant time*group interaction (p=.16, Figure 3). Post-hoc 
paired t tests revealed an average daily MVPA increase of 13 (14.6) minutes for 
the high intensity group (p=0.01, 95% CI 4.8 to 21.2) but no change for moderate 
intensity 5.1 (10.2) minutes (p=0.27, 95% CI -5.6 to 15.80) or waitlist control 3.7 
(12.5) (p = 0.31, 95% CI -3.8 to 11.2). Within group effect sizes for changes in 
average daily MVPA were 0.91, 0.48 and 0.30 for high intensity, moderate 
intensity and waitlist control groups, respectively. Between group comparisons 
using independent t-tests showed that MVPA at five and/or six months was 
higher in the high intensity group compared to both the moderate intensity group 
(mean difference = 14.5 minutes, p= 0.04, 95% CI .41 to 28.7) and waitlist control 
(mean difference = 17.4 minutes, p=0.01, 95% CI 5.7 to 29.1). The moderate 
intensity group obtained higher levels of MVPA compared to waitlist control but 
the difference was not statistically significant (mean difference = 2.9 minutes, 




Relationship between changes in daily steps and fitness 
 For changes in VO2peak, there were no significant main effects for time 
(p=0.81) or group (p=.94); however, a group*time interaction was present 
(p=0.03, Figure 3). A post-hoc one way analysis of variance revealed no 
significant between-group differences in VO2peak at six months (p=0.91).  Within 
group effect sizes (Cohen’s d) for changes in VO2peak were 0.23, 0.10 and -0.44 
for high intensity, moderate intensity and waitlist control groups, respectively. 
Changes in daily steps were not significantly associated with changes in 
VO2peak (r=.183, p=0.16) 
DISCUSSION 
What daily step threshold corresponds to meeting PA guidelines?  
 Using the 4200 steps per day threshold correctly classified 87% of 
participants who met PA guidelines and 96% of participants who did not. In other 
words, those obtaining >4200 steps were 23 times more likely to meet PA 
guidelines compared to those with <4200 steps. At face value, 4200 daily steps 
may appear low, especially compared to the popular 10,000 steps per day60 or 
the frequently cited 7,000 steps per day thresholds.61,62 The aforementioned 
thresholds, however, are geared towards healthy adults. For people with 
disability, there is limited evidence supporting a daily step recommendation24 but 
our value of 4200 daily steps may provide a starting point. Lee et al.31 found that 
just 4400 steps per day was related to a decrease in mortality rate in older 
women. In addition, Lee et al.31 found that after adjusting for daily step count, the 




step counts may be of greater value than metrics of intensity. Because 
Parkinson’s adversely impacts both cognition and mobility, setting a goal of 4200 
daily steps may be a more obtainable target for pwPD as compared to 
assessment of time spent in moderate-intensity PA. To provide further support 
for the recommendation of 4200 daily steps, future longitudinal studies should 
examine the relationship between 4200 daily steps, mortality and other PD-
specific outcomes. 
 Out of 110 participants at baseline (i.e. before intervention), over 75% met 
PA guidelines. Our highly active sample is in contrast to the 27% of participants 
who met PA guidelines in a recent study (n=95).5 Differences found between the 
two studies may be due to differences in participant age (mean age of 73 versus 
our median of 65 years) and disease severity (H&Y II and III versus <III in the 
present study). Furthermore, though the same activity monitor (ActiGraph 
GT3X+) was used, the present study utilized a slightly lower cutoff (i.e. 1,952 vs. 
2,019 counts per minute5) to classify moderate intensity PA and thus the number 
of participants meeting PA guidelines in the present study may have been 
inflated. Because the SPARX trial consisted of a rigorous six month exercise 
intervention, our participants may represent a more active group of pwPD. 
Interestingly, participants who reported performance of moderate-to-vigorous 
aerobic exercise more than twice per week for the last four months were 
excluded from the SPARX trial. The fact that our sample was highly active at 
baseline as measured by activity monitor, reiterates the known discrepancies 




participants may not have been regular exercisers prior to their diagnosis. With a 
median time since diagnosis of less than one year, participants may have 
become physically active only after receiving their PD diagnosis, which could 
have been within the four months prior to beginning the SPARX trial. Though 
MVPA was higher in the current study, daily step counts (4817) were similar to 
previous studies (3615 to 5452)5,27,38 but also lower than others (8686 to 
10,261).30,33,39 Participants in the present study may have accumulated MVPA in 
relatively few bouts, with minimal stepping activity for the remainder of the day. 
For those with <4200 daily steps, what are the effects of treadmill exercise 
performed at varying intensities on PA? 
 Participants with less than 4200 steps at baseline who engaged in high-
intensity treadmill exercise observed a large and significant increase in daily 
minutes spent performing MVPA. For pwPD, the benefits of MVPA are well 
established and include improvements in cardiorespiratory fitness,14,15 fatigue, 
depression, quality of life and slowing of disease progression.14,15 For older 
adults, replacing 10 minutes of sedentary time with 10 minutes of MVPA led to a 
21% risk reduction in mortality.64  While the smallest amount of MVPA required to 
see PD-specific benefits has yet to be determined, current PA guidelines clearly 
state that any amount of MVPA is beneficial to health.20 Thus, when interpreting 
changes in MVPA, especially in those with the lowest activity levels, researchers 
should be encouraged to look at the magnitude of change, rather than just 
statistical significance, to ensure meaningful gains in MVPA are captured. 




moderate-intensity exercise in terms of accumulating MVPA, other factors such 
as participant preference and capability must also be considered when 
prescribing exercise regimens. 
 Participants with less than 4200 steps at baseline who were in the high-
intensity exercise group also observed a large and significant increase in daily 
steps (1220, 95% CI  288 to 2152). While there is no available minimally clinically 
important difference (MCID) for daily step counts in pwPD, in individuals with 
Multiple sclerosis, a change of 800 steps per day reflected changes in participant 
reported walking ability.65 For adults at risk for type 2 diabetes, an increase of 
2000 daily steps was associated with reduced cardiovascular events.66 This last 
finding is pertinent, as pwPD are at greater risk for development of 
cardiovascular disease,10,11 which is responsible for nearly one in five deaths in 
those with PD.12 While only participants in the high-intensity exercise group had 
significant increases in daily steps, there was a medium within group effect size 
for the moderate-intensity exercise group and a miniscule effect size for the 
control group. Though no significant between group differences in daily steps 
were found, this may have been a result of the small number of participants in 
each group. Overall, our results imply that treadmill exercise of any intensity may 
be enough to make positive changes in daily step counts. 
For those with <4200 daily steps, what is the relationship between changes in 
daily steps and cardiorespiratory fitness? 
 In a cross-sectional analysis of the same sample as the present study, 




largest amount of variability (10%) in daily step counts. Using the longitudinal 
data from the SPARX trial, the present study found that changes in daily step 
counts were not significantly associated with changes in VO2peak. This finding is 
not surprising given the lack of significant changes found in VO2peak amongst 
those with <4200 daily steps. While linking step counts to a powerful health 
outcome such as cardiorespiratory fitness would be welcome, the two metrics 
may provide meaningful but unique information. Cardiorespiratory fitness, which 
is considered a clinical vital sign,67 is largely determined by genetics.68 Genetics 
also determines up to 50% of an individual’s response to exercise training.69 On 
the other hand, daily steps are more fluid and vary based on age, gender, 
walking ability, and disease severity,70 as well as other factors such as weather,71 
motivation72 and the physical environment.73 Another possible explanation for the 
lack of a significant association could be due to the fact that steps counts do not 
provide information on intensity. For the least active participants in our sample, 
obtaining MVPA outside of exercise sessions may have been difficult and thus 
daily steps may have been performed predominantly as light-intensity PA. If the 
majority of steps were of light-intensity, changes in cardiorespiratory fitness 
would likely be minimal. For these individuals, increasing light, rather than MVPA, 
may be more feasible.74 The role light-intensity PA plays in health outcomes is 
becomingly increasingly apparent and future research examining light-intensity 







 Strengths of the present study include calculation of a sample-specific 
step threshold to classify those who meet PA guidelines and analysis of pwPD 
with the lowest PA levels (i.e. steps). Nevertheless, the study has several 
limitations. Calculation of the 4200 steps per day threshold relied on two metrics 
(steps and minutes spent in MVPA) which were both derived from the same 
activity monitor. Use of different cutpoints to define MVPA would likely yield a 
different step threshold. As a retrospective study, no power analysis was 
conducted and could explain lack of significant findings between the two exercise 
groups and the waitlist control group. In addition, only 33 participants had <4200 
daily steps at baseline and sample sizes became even smaller when comparing 
groups (i.e. high-intensity, moderate-intensity, waitlist control). Finally, the activity 
monitor cutpoints used to classify sedentary behavior, light-intensity PA and 
MVPA were derived from studies in healthy adults and may not be ideal for 
people with physical impariments.76 Cutpoints to accurately determine PA 
intensity vary by age,77 activity being performed78 and walking speed.79  
Researchers must consider these factors when choosing appropriate cutpoints 
for their sample. 
CONCLUSION 
 The present study determined that for people with de novo PD, 4200 daily 
steps corresponded to meeting PA guidelines. In addition, for those with <4200 
daily steps, high-intensity treadmill exercise led to increases in daily steps and 




fitness. Collectively, our results have important research and clinical implications. 
The least active participants at baseline in both exercise groups outperformed (in 
terms of effect size) the waitlist control group in terms of steps and MVPA. For 
clinicians working with patients recently diagnosed with PD, the 4200 steps per 
day threshold may be used, albeit cautiously, to infer whether or not PA 
guidelines are being met. While the true value of daily step counts is still being 
determined, the present study provides new information on the relationship 
between steps and health, and provides evidence supporting exercise as a tool 
to increase PA in people with de novo PD. Additional work is needed to 
determine the best means of maintaining and continuing to improve both PA and 























Age, years 65 (40, 80) 61.5 (39, 79) 70.5 (48, 80) <0.001b 
Female, n (%) 48 (43.6) 29 (39.2) 19 (52.8) 0.18c 
Time since PD 
diagnosis, years 
0 (0, 5) 0 (0, 5) 1 (0, 4) 0.10b 
MDS-UPDRS 
motor score (III)d 
19 (5, 60) 18.5 (7, 39) 22 (5, 60) 0.06b 
Fear/worry of falling 
(PDQ-39, Item 9)e 
     Never, n (%) 












condition present, n 
(%) 











min/hr wear time, 
mean (SD) 
33.5 (6.1) 32.3 (6.3) 36 (4.8) 0.75g 
Light activity, 
min/hr wear time, 
mean (SD) 
23.3 (5.5) 23.5 (5.8) 22.9 (5.0) 0.21g 
MVPA, min/hr wear 
time 
2.8 (0.1, 9.5) 3.5 (1.3, 9.5) 0.8 (0.1, 3.4) <0.001b 
















Abbreviations: PD, Parkinson’s disease; MDS-UPDRS, Movement Disorder 
Society-Unified Parkinson’s Disease Rating Scale; PDQ-39, Parkinson’s Disease 
Questionaire-39, VO2peak, maximal rate of oxygen consumption during maximal 
graded exercise test, measured in milliliters (mL) per minute (min) per kilogram 
(kg) of body mass; min/hr, minutes per hour; MVPA, moderate-to-vigorous 
intensity physical activity; PA, physical activity 
a Data presented as median (minimum, maximum) unless otherwise stated. 
Physical activity intensity classified as sedentary (<100 counts/min), light (100-
1951 counts/min), moderate (1952-5724 counts/min) and vigorous (>5725 
counts/min).50,51  Boldface indicates significant at p <0.05.  
b Independent samples, Mann-Whitney U test.  
c Pearson Chi-Square, 2-sided 
d The MDS-UPDRS motor score (part III) consists of 33 items including but not 
limited to assessment of speech, upper and lower extremity coordination, sit to 
stand ability and gait. Examiners rate participants on a five pinot scale ranging 
from 0 (normal) to 4 (severe)  with higher scores indicating greater disease 
severity.45  
e Item 9 of the PDQ-39 asks participants, “Due to having Parkinson’s disease, 
how often during the last month have you felt frightened or worried about falling 
over in public?” Participants respond via five-point Likert scale ranging from 
“never” to “always.”46 The present study followed previously reported methods37 
and dichotomized responses to item 9 by considering any response other than 
“never” as having fear or worry about falling present. 
f VO2peak data was missing from one participant (n=109) in the <4200 steps/day 
group (n=35) 
g Independent samples t-test, 2-sided 
h Physical activity guidelines are from the U.S. Department of Health and Human 
Services which recommend adults participate in at least 150 minutes of 
moderate-intensity physical activity each week.20
Meets aerobic PA 
guidelines, n (%)h 
84 (76.4) 73 (98.6) 11 (30.6) <0.001c 









Monitor wear time, 
min, mean (SD) 




Table 2.2 Accuracy of Daily Step Count and VO2peak to Classify People with 




Abbreviations: AUC, area under the receiver operating characteristics curve; 
95% CI, 95% confidence interval; VO2peak, maximal rate of oxygen 
consumption during maximal graded exercise test, measured in milliliters (mL) 
per minute (min) per kilogram (kg) of body mass; +LR, positive likelihood ratio; -
LR, negative likelihood ratio 
a Physical activity guidelines are from the U.S. Department of Health and Human 
Services which recommend adults participate in at least 150 minutes of 
moderate-intensity physical activity each week.20 Using the daily step count 
threshold of 4197 steps correctly classified 87% (sensitivity) of participants who 
met/exceeded 150 minutes of MVPA and 96% (specificity) of participants who did 
not meet guidelines. Participants meeting/exceeding aerobic physical activity 
guidelines were between 7.72 and 68 times more likely to have at least 4200 
steps compared to those not meeting guidelines. Boldface indicates significant at 
p <0.001. 
b An AUC value of 1.0 indicates a perfect diagnostic test, whereas an AUC of 0.5 
is equal to chance (i.e. the test has no value).  
Thresholds 
AUCb   
(95% CI) Sensitivity Specificity 
+LR  
(95% CI) 




0.95    
(.90 to 1.00) 
87% 96% 
23           
 (7.72 to 
68) 
0.14          









































Female, n (%) 17 (51.5) 10 (71.4) 2 (33.3) 5 (38.5) 0.14c 
Time since PD 
diagnosis, 
years 















39, Item 9)c 
     Never (%) 
















present, n (%) 
















wear time,                       
mean (SD) 





min/hr wear  








Abbreviations: PD, Parkinson’s disease; PDQ-39, MDS-UPDRS, Movement 
Disorder Society-Unified Parkinson’s Disease Rating Scale; Parkinson’s Disease 
Questionaire-39, VO2peak, maximal rate of oxygen consumption during maximal 
graded exercise test, measured in milliliters (mL) per minute (min) per kilogram 
(kg) of body mass; min/hr, minutes per hour; MVPA, moderate-to-vigorous 
intensity physical activity; PA, physical activity 
a Data presented as median (minimum, maximum) unless otherwise stated. 
Physical activity intensity classified as sedentary (<100 counts/min), light (100-
1951 counts/min), moderate (1952-5724 counts/min) and vigorous (>5725 
counts/min) 
b Kruskal–Wallis one-way analysis of variance 
c Pearson Chi-Square, 2-sided;  
d VO2peak data was missing from two participants (n=31) with one from high-
intensity group (n=13) and one from waitlist control group (n=12) 
e One-way analysis of variance 
f Physical activity guidelines are from the U.S. Department of Health and Human 
Services which recommend adults participate in at least 150 minutes of 


















10 (30.3) 7 (50) 1 (16.7) 2 (15.4) 0.11c 


















Figure 2.1 Flow Diagram of Participant Data 
 
Abbreviations: NINDS, National Institute of Neurologic Disorders and Stroke; 
MVPA, moderate-to-vigorous intensity physical activity; VO2peak, maximal rate 
of oxygen consumption during maximal graded exercise test, measured in 




Participants with step data 
received from NINDS dataset
N = 115
Excluded participants with reasons
n = 5 – less than four valid days with step data
Participants analyzed
N = 110
Participants with <4200 daily steps 
on average
N = 36
Participants analyzed for 




Waitlist control group (n=13)
Excluded participants with reasons
n = 2 – no exercise step data
n = 1 – less than four valid days with step data
Participants analyzed for 
differences in VO2peak & changes 




Waitlist control group (n=12)
Excluded participants with reasons
n = 1 – no VO2peak data at baseline


























Figure 2.2 Receiver Operating Characteristics Curves for Average Daily Steps 
and VO2peak to Classify People with Parkinson’s Disease as Meeting or Not 
Meeting Aerobic Physical Activity Guidelinesa  
 
Abbreviations: VO2peak, maximal rate of oxygen consumption during maximal 
graded exercise test, measured in milliliters (mL) per minute (min) per kilogram 
(kg) of body mass; 
a Physical activity guidelines are from the U.S. Department of Health and Human 
Services which recommend adults participate in at least 150 minutes of 
moderate-intensity physical activity each week.20 Dashed reference line indicates 
a test that randomly classifies a condition (i.e. a test with 50% accuracy).  
b Optimal daily step threshold found in the present study  






Figure 2.3 Within and Between Group Comparison of A) Average Daily Steps, B) 


























































































































Abbreviations: MVPA, moderate-to-vigorous intensity physical activity; VO2peak, 
maximal rate of oxygen consumption during maximal graded exercise test, 
measured in milliliters (mL) per minute (min) per kilogram (kg) of body mass. 
a Data presented as means with vertical black bars indicating 95% Confidence 
Intervals. For all dependent variables (steps, MVPA, VO2peak), groups were not 




CHAPTER 3: DAILY STEP COUNT AND BALANCE AT TWO 
MONTHS POST-STROKE ARE THE STRONGEST PREDICTORS 
OF DAILY STEPS AT ONE YEAR POST-STROKE 
INTRODUCTION 
 Improving walking ability is a predominant goal for people after stroke.80 
Not surprisingly, rehabilitation primarily focuses on regaining and improving 
walking ability.81 While components of walking, including speed and endurance, 
have been heavily researched and shown to improve in response to 
interventions,16,18,82 there has recently been an increased interest in free-living 
walking behavior, as measured by daily step counts.23,32,40,83 Unlike walking 
speed or endurance, daily steps are thought to represent participation outside the 
clinical environment and thus offer a unique insight into physical activity (PA) and 
walking behavior.82,84 Daily steps may even predict future health outcomes, with 
attainment of >6000 steps related to a decreased risk for subsequent 
cardiovascular disease in adults with stroke.85 Decreasing risk in adults with 
stroke is paramount considering nearly one in four survivors will experience a 
second stroke,86 which is often more debilitating and deadly than their initial 
stroke.8,87 
 Examination of what contributes to daily steps after stroke is needed in 




meta-analysis88 examined correlates of PA (including daily steps) in people with 
stroke and found that the modifiable factors of physical function, cardiorespiratory 
fitness, fatigue, falls and balance self-efficacy, depression and health-related 
quality of life were significantly associated with PA, in addition to the 
nonmodifiable factors of age and sex. A limitation to this analysis was that the 
majority of the included studies were cross sectional, used subjective measures 
(i.e. participant-reports) of PA, or included only those in the chronic (i.e. > 6 
months) phase of stroke. Ideally, identification of people with stroke at risk for 
leading insufficiently active lifestyles would be done as close to stroke onset as 
possible. In this manner, individualized education and behavioral interventions 
could be implemented early for those most at risk for poor health outcomes 
associated with physical inactivity.  
 The purpose of the present study was twofold: 1) determine which factors 
(both nonmodifiable and modifiable) present at two months post-stroke can 
predict daily step counts at one year post-stroke and 2) determine a daily step 
threshold at two months post stroke that corresponds to obtaining >6000 daily 
steps at one year post-stroke.  
METHODS 
Study Design and Participants 
 The present study is a secondary analysis of deidentified data from the 
National Institute of Neurologic Disease and Stroke’s (NINDS) Archived Clinical 
Research data (Locomotor Experience Applied Post-Stroke [LEAPS], Pamela W. 




Dataset website. The LEAPS trial was a three arm, single blinded, phase III 
randomized controlled trial, which examined the effects of three interventions 
(early body weight–supported treadmill training at two months post-stroke, late 
body weight–supported treadmill training at six months post-stroke, and a 
progressive supervised home exercise program) on self-selected walking 
speed.16 Adults were screened between 5 and 30 days after experiencing an 
initial stroke and, after a baseline assessment at two months post-stroke, 
randomized to one of the three groups. Each intervention consisted of 36 
sessions lasting 90 minutes each and performed for a total of 12 to 16 weeks. 
Results demonstrated no superiority of any treatment group, with 52% of all 
participants transitioning from a walking speed of [<0.40 m/s to >0.40 m/s] or 
[between 0.40 m/s to <0.80 m/s] to >0.80 m/s. In addition, 52% of participants 
attained clinically meaningful improvements in daily steps at one year post-
stroke. During the trial, 82% of participants received physical therapy (outside of 
study) with 74% of therapy provided in an outpatient setting between two and six 
months post-stroke.16 Ethical approval for the LEAPS trial was obtained from 
several associated institutional review boards and all participants provided 
informed consent prior to participation.16 The secondary analysis used in the 
present study was not considered human subjects research and received 
exemption from the University of South Carolina’s institutional review board. 
 Criteria for inclusion and exclusion in the LEAPS trial have been 
reported.16,89 To be included in the trial, participants had to have a first time 




without help from another person and have a self-selected walking speed of 
<0.80m/s. Eligible participants were then randomized to one of three treatment 
groups. Participant data was collected at multiple time points during the trial but 
the present study analyzed only data at baseline (two months post-stroke) and 
one year post-stroke (the final assessment).  
Daily Step Counts 
 Daily steps were measured on two consecutive days at baseline (two 
months post-stroke) and at one year post-stroke using the highly reliable90,91 and 
valid23,92 StepWatch Activity Monitor (Orthocare Innovations, Oklahoma City, OK, 
USA). Participants were instructed to wear the monitor on the non-paretic ankle 
during all waking hours with the exception of water-based activities (e.g., bathing 
or swimming).93 For step data to be considered valid for the present study, 
participants needed two days of monitoring94 with an overall average monitor 
wear time of at least 10 hours95 at two months and at one year post-stroke. The 
average daily step count for the two days of monitoring was used for analysis. 
Participants without valid step data were excluded. 
Candidate Predictors of Daily Steps – Nonmodifiable 
Nonmodifiable factors previously found to be associated with PA in people 
with stroke were examined as potential predictors of daily steps. These factors 
included age and gender (males accumulating more PA than females),88 race 
and/or ethnicity (Hispanics and non-Hispanic black adults obtaining less PA than 
non-Hispanic whites),96 and initial stroke severity97 (measured at the initial screen 




Candidate Predictors of Daily Steps – Modifiable 
 Modifiable factors previously found to be associated with PA in people 
with stroke88 were also examined as potential predictors of daily steps and 
included:  
Self-selected100 and fast paced24 walking speed, which were measured as 
the time taken to walk 10 m (at either a self-selected or a fast pace) with an 
untimed 3 m section both preceding and following the timed 10 m section.89 
The Six Minute Walk test101  which assessed walking endurance by having 
participants walk as far as they could in 6 minutes using a standardized 
protocol.26 A path of ~30 m (100 ft) was used for the test and results were 
recorded as meters walked. 
The Lower extremity Fugl-Meyer Assessment102 which assessed motor 
impairment with scores ranging from 0 to 34, with higher scores indicating less 
impairment. 
The Berg Balance Scale103 which assessed balance and consists of 14-
items scored 0 to 4 with a maximum score of 56 (indicative of higher balance and 
mobility). 
Cardiorespiratory fitness which was assessed via an exercise tolerance 
test (stationary bicycle) performed just prior to randomization.89,104 Participants 
began pedaling at 40-60 revolutions per minute with increasing workload 
increments of 10 watts per minute. The test was stopped when maximum effort 
was reached (defined as reaching 90% of age predicted maximum heart rate or a 




symptoms limited completion of the test (e.g. a blood pressure reading that 
warranted cessation of exercise). Exercise duration during the test was recorded 
and used for analysis. 
The Activities Specific Balance Confidence Scale,105 which is a 
participant-reported measure that asks participants to rank their level of 
confidence for performing 16 different tasks (e.g. walk around the house and 
walk up and down a ramp). Scores range from 0 to 100% with higher scores 
indicating greater balance confidence. 
The Patient Health Questionnaire (PHQ-9),106 which is a 9 item participant 
reported measure examining the presence and severity of depressive symptoms 
with a score >10 suggestive of major depression.  
The Stroke Impact Scale (mobility and participation dimensions),107 which 
is a participant-reported measure examining disability and health related quality 
of life with higher scores indicating less disability and greater quality of life.  
Daily Steps at two-months post-stroke was also examined as a candidate 
predictor of future PA and was measured via activity monitor. 
 Additionally, in older adults, being married,108 employed, and having a 
higher level of education has also been associated with increased PA109 and 
were considered candidate predictors of daily steps. 
Data Analysis 
 A priori power analysis using G*Power was performed to determine the 
sample size needed to achieve an R2 value of 0.25 (effect size f2 of 0.33), with 18 




on a meta-analysis which showed that most factors explained <30% of the 
variance in PA in people with stroke.88 The minimum sample size needed to 
conduct the analysis was determined to be 77 participants. 
 Univariate analysis using Pearson’s r (or Spearman’s rho [rs] for ordinal 
data) was performed to determine the association between candidate predictors 
(independent variables assessed at two months post-stroke) and average daily 
step counts at one year (dependent variable). Candidate predictors found to be 
statistically significantly associated (P<0.05) with daily step counts were entered 
into multivariate analysis with dummy coding applied for categorical predictors. 
Forward selection stepwise regression determined the strongest predictors (i.e. 
largest R2 values) of daily steps at one year post-stroke, using a probability of 
<0.05 for a predictor to enter the model and >0.10 for a predictor to be removed. 
Forward selection was used to minimize the number of predictors in the model 
and arguably make assessment of such predictors more clinically feasible (i.e. 
clinicians will need to assess fewer factors to gain insight into future PA levels). 
Predictors found to exhibit multicollinearity (determined as a variance inflation 
factor or VIF >5)110 were removed from the model. 
 Step data at one year post-stroke was used to classify participants into 
two groups (participants with <6000 and participants with >6000 daily steps) and 
descriptive statistics were calculated. A step count of 6000 was chosen as it has 
been found to be related to a decreased risk for subsequent cardiovascular 





Demographic variables between the two groups were compared through 
independent t-tests or Mann-Whitney U tests, and chi-squared tests.  
 To determine a daily step threshold at two months post-stroke 
(independent variable) which corresponds to obtaining >6000 steps at one year 
post-stroke (dependent variable), receiver operating characteristic (ROC) curves, 
including the area under the curve (AUC) were generated.56 Sensitivity, 
specificity, likelihood ratios and Youden’s index (J)57 were calculated. J can be 
used to identify optimal thresholds for diagnostic tests.58 The highest J value was 
chosen as the optimal threshold to accurately classify participants as obtaining 
<6000 or >6000 daily steps. All data were analyzed using IBM SPSS Statistics 
for Macintosh, Version 26.0 (IBM SPSS, Chicago, IL, USA).  
RESULTS 
 A flow diagram of how participant data were used is displayed in Figure 1. 
After removal of participants with invalid data and a single outlier (in terms of 
daily steps), data from 206 participants were analyzed (in Table 1). Participants 
averaged 63 years of age with a median self-selected walking speed of 0.42m/s 
and an average of 2922 daily steps. 
 Eight modifiable factors at two months post-stroke were found to be 
significantly associated with daily steps at one year post-stroke: self-selected 
(r=.371, p=<0.001) and fast paced (r=.401, p=<0.001) walking speed, walking 
endurance (r=.476, p=<0.001), lower extremity impairment (rs=.308, p=<0.001), 
balance (rs=.473, p=<0.001),  average daily steps at two-months (r=.598, 




confidence (r=.231, p=<0.001). The only nonmodifiable factor significantly 
associated with daily steps at one year post-stroke was initial stroke severity (rs=-
.333, p=<0.001). Forward selection regression was performed using these 9 
factors. The first to enter in the model was average daily steps at two months 
post-stroke which yielded an adjusted R2 of 0.36. The final model added balance 
(Berg Balance Scale score) and increased the adjusted R2 to 0.39 (increase of 
0.03); both models were significant at p=<0.001. No other factors significantly 
increased R2 and no multicollinearity was observed. The final regression equation 
is below and a graphical representation of the equation is shown in Figure 2. 
Predicted daily steps at one year-post stroke= 
1031 +0.56(daily steps at two months post-stroke)+47(Berg Balance Scale 
score) 
 Descriptive data and a comparison of participants with <6000 and >6000 
daily steps at one year post-stroke is displayed in Table 2. Participants with 
<6000 daily steps at one year had slower walking speeds, less walking 
endurance, greater lower extremity impairment, greater balance impairment, less 
balance confidence, greater self-reported mobility limitations and an increased 
initial stroke severity at two months post-stroke as compared to those with >6000 
daily steps. The step count with the highest J value was 1632 steps, which had a 
corresponding sensitivity of 86% and specificity of 54% (Table 3).  
DISCUSSION 
 The present study utilized longitudinal data from the LEAPS trial to 




(i.e. daily steps). A total of 18 nonmodifiable and modifiable factors were 
examined as potential predictors of daily steps at one year post-stroke, nine of 
which had significant associations with daily steps. However, only daily steps and 
Berg Balance Scale score at two months post-stroke remained in the final 
prediction model, which accounted for 39% of the variance in daily steps at one 
year post-stroke. 
 Previous research examining prediction, rather than association, of PA 
post-stroke is limited. A recent study examined daily steps in people with stroke 
after discharge from inpatient rehabilitation and again three months later.111 
Predictors of daily steps at follow up included self-selected walking speed and 
balance. A separate twelve month exercise intervention study found that walking 
endurance, balance and health related quality of life explained 33% of the 
variance in daily steps one year later.112 While an R2 value of 33% is similar to 
our 39%, the previous study involved individuals with chronic stroke as opposed 
to our study which followed individuals from the subacute (i.e. between two 
weeks and six months post-stroke) to chronic (i.e. >six months post-stroke) 
phase of stroke.113 While walking ability can be improved years after stroke 
onset,114 the majority of recovery happens within the first six months.115 Thus, for 
providers treating individuals with stroke in the sub-acute phase, our results may 
be more pertinent. Clearly, evidence supports assessment of both walking ability 
and balance early and often during stroke recovery. However, if PA is the primary 
outcome of interest, our results indicate that there is no greater predictor of future 




should be assessed to gain insight into future PA. Fortunately, assessment of PA 
and specifically steps, is becoming easier with the use of commercially available 
wearables116 that provide users with a single metric that may be used to set 
goals and track progress with PA. 
 While participants’ balance scores explained only an additional 3% of the 
variance in daily steps at one year post-stroke, balance is consistently related to 
daily steps post-stroke and therefore important to assess. Numerous studies 
have found that greater balance is related to greater PA, including daily 
steps.111,112,117,118 In our sample, participants who did not reach at least 6000 
daily steps at one year post-stroke, had poorer balance scores (median of 39/56) 
than those who did reach 6000 steps (median of 46/56). Both elderly adults and 
individuals with acute stroke who score <45 on the Berg Balance Scale are at a 
heightened risk for falls119 and this could have negatively impacted PA levels. 
Previous falls and a fear of falling are associated with reduced daily steps in 
older adults.120 This finding is supported by decreased balance confidence 
scores observed for participants with less than 6000 daily steps. Collectively, 
balance is an important metric to measure after stroke, not only to assess fall risk 
but also to gain additional insight into future PA levels. 
  PA is immensely beneficial in all stages of stroke recovery, with 
performance of additional PA providing additional health benefits.121 Despite this, 
nearly three fourths of our participants obtained <6000 daily steps at one year-
post stroke. The daily step count found in the present study is consistent with 




sessions of supervised, structured and progressive exercise. While the majority 
(52%) of participants in the LEAPS trial had clinically meaningful improvements 
in daily steps (regardless of group allocation),16 the intervention’s main purpose 
was to increase walking ability (chiefly, walking speed) not daily walking 
behavior. There is growing evidence that combining aerobic exercise (i.e. 
walking) with a behavioral change intervention improves PA levels after stroke.32 
These findings however, remain to be seen in the acute and subacute phases of 
rehabilitation, where providers are focused on restoring patient function, rather 
than improving overall fitness or PA levels.122 For providers working with 
individuals in the subacute phase of stroke, encouraging >1632 daily steps can 
serve as a preliminary target that corresponds to reaching >6000 daily steps at 
one year. Future research examining the utility of >1632 daily steps will be 
required to support or refute our findings, followed by interventions to determine if 
achieving 1632 daily steps is feasible and effective at improving health after 
stroke. 
 Daily step counts can provide valuable insight into future health outcomes 
but much of our understanding comes from populations without cardiovascular 
disease. For example, in adults at risk for type 2 diabetes, increasing daily steps 
by 2000 was associated with an 8% reduction in cardiovascular events.66 To our 
knowledge, only one study to date has examined the relationship between step 
count and subsequent cardiovascular events in people with stroke. Kono et al85 
assessed participants’ daily steps at three months and again at three years post-




events. Their sample, however, consisted of higher functioning individuals with 
mild disability. In contrast, the present sample consisted of participants with a 
variety of functional levels and only followed participants up to one year-
poststroke. As a result, long-term outcomes such as cardiovascular events could 
not be assessed. Additional longitudinal studies with longer follow up periods will 
be required to determine the role daily steps play in terms of subsequent stroke 
risk, which is a stroke research priority.123 
Strengths & Limitations 
 A major strength of the present study is the large sample size, which 
allowed adequate power to examine numerous predictors of PA. Additional 
strengths include the use of an objective activity monitor to measure steps and 
assessment of individuals with moderate to severe gait impairments (i.e. gait 
speed <0.8m/s). Still, the present study has several limitations. For one, potential 
predictors of PA were limited to those collected in the LEAPS trial. Factors known 
to be associated with PA such as motivation111 or fatigue124 were not examined, 
nor were qualitative components such as outcomes expectations or social 
support.125 Additional details on what precluded participants from performing 
more PA may help guide interventions. In addition, our findings only apply to 
participants who adhered to wearing the activity monitor at both two months and 
one year post-stroke. Previous research using data from the LEAPS trial found 
that adherence to wearing the activity monitor was reduced in younger 
participants with reduced balance confidence and walking endurance.93 Because 




the current analysis. Finally, we chose 6000 daily steps as a metric of a positive 
outcome (i.e. reduced risk of subsequent cardiovascular event) but this number 
was based on a single study. Thus, our resulting threshold of 1632 daily steps (at 
two months post-stroke) that corresponds to obtaining > 6000 steps at one year 
post-stroke should be used with caution.   
CONCLUSION 
 In summary, the present study found that the strongest predictors of daily 
steps at one year post-stroke were daily steps and Berg Balance Scale scores 
assessed at two-months post-stroke. When working with individuals with stroke 
in the subacute phase, promotion of daily walking, in addition to targeted balance 
interventions, may lead to future increases in PA. Though there is no consensus 
as to how many daily steps people with stroke should be taking, a preliminary 
target for those two months post-stroke is at least 1632 steps per day. Further 
research examining daily steps in people with stroke is needed to determine 
















Age, years, mean (SD) 63 (12.7) 
Male, n (%) 118 (57.3) 
Non-Hispanic White, n (%) 101 (49) 
Married, n (%) 128 (62.1) 
Employed at least part time, n (%) 104 (50.5) 
Completed at least some college, n (%) 117 (56.8) 
Self-selected walking speed, m/s 0.42 [0, 0.78] (0.37) 
Fast walking speed, m/s 0.55 [0, 1.22] (0.49) 
Walking endurance (Six Minute Walk Test), m 136.5 [0, 315] (113.5) 
Cardiorespiratory fitness (maximal exercise test), 
test duration, minutes 
24.9 [0, 60] (30.5) 
Daily steps, mean (SD) 2922 (2749) 
Motor function (Lower extremity Fugl-Meyer) 26 [8, 34] (9.19) 
Balance (Berg Balance Scale) 41 [0, 56] (18) 
Balance confidence (Activities Specific Balance 
Confidence Scale), % 
48.5 [0, 100] (34.1) 
Participant-reported mobility (Stroke Impact 
Scale) 




Participant-reported participation (Stroke Impact 
Scale) 
43.75 [0, 100] (32.03) 
Patient Health Questionnaire (PHQ-9)106 3 [0, 24] (5) 
Initial stroke severity (NIHSS) 6 [0, 20] (5) 
Activity monitor wear time, hours, mean (SD) 20.8 (4.8) 
 
Abbreviations:  m/s, meters per second; m, meters; NIHSS, National Institutes of 
Health Stroke Scale 
a Data presented as median [minimum, maximum]  (IQR) unless otherwise stated 
b One outlier with 29864 steps at one year (more than 5 standard deviations from 


































Table 3.2 Comparison of Descriptors At Two Months Post-Stroke Between 












Age, years, mean (SD) 64 (13) 61 (12) 0.151b 
Male, n (%) 82 (55) 36 (63) 0.292c 
Non-Hispanic White, n (%) 75 (50) 26 (46) 0.544c 
Married, n (%) 89 (60) 39 (68) 0.250c 
Employed at least part time, n (%) 71 (48) 33 (58) 0.188c 
Completed at least some college, 
n (%) 
84 (56) 
33 (58) 0.844c 
Self-selected walking speed, m/s 





Fast walking speed, m/s 





Walking endurance (Six Minute 
Walk Test), m 
121 [0, 315] 
(103) 
178 [0, 306] 
(108) 
<0.001d 
Cardiorespiratory fitness (maximal 
exercise test), test duration, 
minutes 








Daily steps at two months post-
stroke, mean (SD) 
2218 (2151) 
4761 (3267) <0.001b 
Daily steps at one year post-
stroke, mean (SD) 
2870 (1704) 
8503 (2059) <0.001b 
Motor function (Lower extremity 
Fugl-Meyer) 
25 [9, 34] (10) 
27 [8, 34] (8) 0.036d 
Balance (Berg Balance Scale) 39 [0, 56] (18) 46 [21, 55] (12) <0.001d 
Balance confidence (Activities 
Specific Balance Confidence 
Scale), % 
44 [0, 99] (33) 




(Stroke Impact Scale) 
61 [3, 100] 
(28) 
67 [8, 100] (26) 0.043d 
Participant-reported participation 
(Stroke Impact Scale) 
44 [0, 100] 
(34) 
44 [6, 100] (30) 0.838d 
Patient Health Questionnaire 
(PHQ-9)106 
3 [0, 24] (6) 
2 [0, 18] (5) 0.664d 
Initial stroke severity (NIHSS) 7 [0, 20] (4) 5 [0, 19] (4) 0.017d 
Activity monitor wear time, hours, 
mean (SD) 
21.1 (4.7) 
20.1 (5.2) 0.170b 
 
Abbreviations: m/s, meters per second; m, meters; NIHSS, National Institutes of 
Health Stroke Scale 
a Data presented as median (minimum, maximum) unless otherwise stated. 
Boldface indicates significant at p <0.05.  
b Independent samples t-test, 2-sided 
c Pearson Chi-Square, 2-sided 




Table 3.3 Accuracy of Daily Step Count At Two-Months Post-Stroke To Classify 
Who Will Reach >6000 Steps At One Year Post-Stroke.a 
 
 
Abbreviations: AUC, area under the receiver operating characteristics curve; 
95% CI, 95% confidence interval; +LR, positive likelihood ratio; -LR, negative 
likelihood ratio 
a Using the daily step count threshold of 1632 steps correctly classified 86% 
(sensitivity) of participants who obtained >6000 daily steps at one year post-
stroke and 54% (specificity) of participants who did not. Participants who 
obtained >6000 steps at one year were between 1.52 and 2.27 times more likely 
to average at least 1632 steps at two months post-stroke compared to those who 
did not obtain 6000 steps. Boldface indicates significant at p <0.001. 
b An AUC value of 1.0 indicates a perfect diagnostic test, whereas an AUC of 0.5 
is equal to chance.
Threshold 
AUCb   
(95% CI) Sensitivity Specificity 
+LR  
(95% CI) 




0.76    
(0.69 to 0.83) 
86% 54% 
1.86           
 (1.52 to 
2.27) 
0.26          







Figure 3.1 Flow Diagram of Participant Data 
 









Figure 3.2 Predicted Average Daily Steps At One Year Post-Stroke Based On 
Steps At Two Months and Berg Balance Scale Score. 
 
Figure depicts arbitrary daily step counts and Berg Balance Scale scores at two 
months post-stroke and how these factors may predict daily steps at one year. 
Figure provides a hypothetical example of the regression equation:  
Predicted daily steps at one year-post stroke= 









Average Daily Step Count 
At Two Months Post-Stroke
Predicted Average Daily Step Count 
At One Year Post-Stroke



















CHAPTER 4: EXAMINATION OF DAILY STEPS IN PEOPLE WITH 
PARKINSON’S DISEASE & STROKE 
 Overall, there is little evidence to guide daily step recommendations for 
those with PD or stroke. For pwPD or stroke, the aforementioned studies 
(Chapters 2 and 3) identified daily step counts associated with health outcomes 
(meeting PA guidelines for pwPD and obtaining >6000 and perhaps reducing risk 
of cardiovascular events for those with stroke). Collectively, results from both 
studies can be used to inform future interventions aimed at improving PA for both 
groups.  
Daily Steps In People With Parkinson’s Disease 
 For people newly diagnosed with PD, PA can reduce symptoms and 
disease progression. Results from our study found that individuals taking at least 
4200 daily steps were much more likely to meet PA guidelines compared to 
those who took less than 4200 daily steps. Thus, a step count of 4200 steps per 
day can be used as a starting point for when a newly diagnosed individual asks, 
“how much should I walk?” A step count of 4200 daily steps may also be more 
realistic for individuals with greater disability who may not be able to engage in 
long, intense bouts of PA. While translating PA guidelines (150 minutes of 
moderate-intensity aerobic activity) into steps is salient for those who accumulate 
most of their PA from walking, PA guidelines are backed by a larger body of 




simply replace PA guidelines with step guidelines. Our recommendation of 4200 
daily steps will need to be tested, preferably in longitudinal studies, to determine 
its role in long term health outcomes including disease progression, 
cardiovascular events and mortality.   
 Recruitment of physically inactive individuals into an exercise intervention 
can be difficult, as was found with our study in Chapter 2 (75% of participants 
were meeting PA guidelines at baseline). Using the entire sample of participants 
with de novo PD (n=110), other authors found no differences in daily steps at the 
six month assessment.14 Authors went on to suggest that those allocated to an 
exercise group (i.e. high or moderate-intensity treadmill exercise) may have 
reduced the number of steps taken outside the intervention so that average daily 
steps remained unchanged. Our study examined daily steps in the least active 
individuals (i.e. those with the least steps) and found that for those in the high-
intensity group, there was indeed a significant increase in both steps and MVPA. 
This finding would have gone undetected if not for closer inspection of the least 
active participants, who arguably stand to benefit the most form increasing PA 
levels. There is overwhelming evidence of a dose-response relationship in terms 
of PA and health benefits. Thus, even small increases in PA, including daily 
steps, are likely beneficial and should be examined. 
Daily Steps In People With Stroke 
Using a sample of 206 individuals who were two months post-stroke, we 
found that daily steps and balance were the strongest predictors of PA at one 




physical function and PA, our study represents the largest longitudinal 
examination of the predictors of PA. Our results suggest that targeting PA (e.g. 
daily walking) and balance at two months post-stroke may lead to higher 
amounts of PA at one year. While walking is the predominant intervention 
employed in rehabilitation early after stroke, much of the intervention is focused 
on the quality of gait, with little to no attention paid to community walking or 
overall PA levels. At first glance, our findings seem obvious: in order to walk 
more in the future, you should walk more now. However, our study is the first to 
explicitly determine that PA early after stroke predicts future PA. This information 
may be valuable to providers working with individuals early after stroke and may 
prompt the initiation of behavioral change interventions, alongside standard 
rehabilitation, to improve PA and subsequent health of people living with stroke.  
 While we determined that 1632 steps at two months post-stroke was the 
optimal step count for determining who would reach >6000 daily steps at one 
year, with a sensitivity of 86%, the step count should be used cautiously. At each 
assessment period, steps were only monitored for two consecutive days and thus 
provide a small window in which to view PA. It is possible that our determined 
step count would have been different if data were collected for a longer period of 
time. Future longitudinal studies, employing repeated assessments, may provide 
a more accurate account of daily stepping after stroke and better inform future 
PA recommendations. Overall, few participants ( ~28%) in our sample 
obtained >6000 daily steps at one year. This finding reinstates the need for 




Future Directions  
 Using two large and publicly available datasets, the two aforementioned 
studies provided meaningful insight into daily step counts in two groups of people 
(pwPD and people with stroke) who face an increased risk for further disability 
and death due to physical inactivity. The daily step thresholds determined in the 
proposed studies may be used as preliminary targets for interventions aimed at 
improving PA in pwPD and stroke. Subsequently, future research can begin to 
use findings from the proposed studies to better describe daily step counts and 
their relationship to overall health and wellbeing. Nevertheless, there is a dire 
need for interventions that successfully increase the PA levels in both pwPD and 
stroke. These interventions may begin to elucidate the relationship between daily 
steps and health outcomes such as cardiovascular events, hospitalizations 
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